Search
for
Sort by
Research 181–210 of 1000+
- Changes in dermatological complaints among healthcare professionals during the COVID-19 outbreak in Turkey
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Androgen deprivation therapy and hormonal status in men with COVID-19
- In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
- Psychological burden of alopecia areata in patients with cancer: A narrative review
- A Case of Telogen Effluvium as COVID Sequelae
- After Math of COVID Through Eyes of Tricoscopy
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation
- Alopecias
- 51895 Interim Analysis of Platelet-Rich Plasma (PRP) Treatment for Endocrine Therapy-Induced Alopecia (EIA) and Permanent Chemotherapy-Induced Alopecia (pCIA) in Breast Cancer Patients: A Randomized Controlled Trial
- Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19
- Eflúvio Telógeno após a infecção por COVID 19: uma revisão narrativa sobre o mecanismo fisiológico / Telogen Effluvium after SARS-CoV-2 infection: a narrative review of physiological mechanism
- Telogen effluvium in the new SARS‐CoV‐2 era
- Global Epidemiology of Telogen Effluvium after COVID-19 Pandemic: A Systematic Review and Modeling Study
- Self-Reported Hair Loss Following COVID-19: An Observational Study
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- COVID-19-associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study.
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- Telogen Effluvium After COVID-19 Infection: A Case Report
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID ‐19
- Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19
- Tamoxifen-induced androgenetic alopecia in a dialysis patient with sclerosing encapsulating peritonitis (SEP)
- Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants